Jane Street’s CareDx CDNA Stock Holding History

Jane Street’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$274K	Buy	+9,600	New	+$209K	﹤0.01%	9423
2026 Q1	–	Sell	-49,200	Closed	-$927K	–	11690
2025 Q4	$927K	Sell	49,200 -20,200	-29%	-$338K	﹤0.01%	6275
2025 Q3	$1.01M	Buy	+69,400	New	+$989K	﹤0.01%	6298
2024 Q2	–	Sell	-21,800	Closed	-$231K	–	9425
2024 Q1	$231K	Buy	+21,800	New	+$218K	﹤0.01%	7973
2023 Q4	–	Sell	-19,300	Closed	-$135K	–	9230
2023 Q3	$135K	Buy	19,300 +6,300	+48%	+$58.2K	﹤0.01%	7837
2023 Q2	$111K	Buy	+13,000	New	+$108K	﹤0.01%	7961
2022 Q2	–	Sell	-8,700	Closed	-$322K	–	9731
2022 Q1	$322K	Sell	8,700 -11,400	-57%	-$444K	﹤0.01%	8284
2021 Q4	$914K	Sell	20,100 -3,900	-16%	-$204K	﹤0.01%	6082
2021 Q3	$1.52M	Buy	24,000 +5,200	+28%	+$396K	﹤0.01%	5037
2021 Q2	$1.72M	Sell	18,800 -28,300	-60%	-$2.25M	﹤0.01%	4633
2021 Q1	$3.21M	Sell	47,100 -106,500	-69%	-$8.27M	﹤0.01%	3122
2020 Q4	$11.1M	Buy	153,600 +134,200	+692%	+$7.78M	0.01%	1326
2020 Q3	$736K	Buy	19,400 +10,100	+109%	+$341K	﹤0.01%	4586
2020 Q2	$329K	Buy	+9,300	New	+$265K	﹤0.01%	5698

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's CDNA Position: Q2 2026 in Review

Jane Street increased its CareDx (CDNA) stake by 88% in Q2 2026, buying an estimated $4.79M and bringing the position to 470,273 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2517.

Jane Street first reported a position in CDNA in Q3 2019 and has held it in 23 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Jane Street held 470,273 shares of CareDx worth $13.4M as of Q2 2026.
Jane Street bought 219,922 CareDx shares in Q2 2026, an estimated $4.79M.
CareDx made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2517 holding.
Jane Street first reported a position in CareDx in Q3 2019 and has held it in 23 quarters since.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.